Pharmerica Revenue

Pharmerica revenue was $2.09 b in FY, 2016 which is a 3.1% year over year increase from the previous period.

Embed Graph

Summary - Funding Rounds

Pharmerica is a subsidiary of KKR & Co. (Kohlberg Kravis Roberts & Co.)

Pharmerica Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.8b1.9b2.0b2.1b

Revenue growth, %

8%7%3%

Cost of goods sold

1.4b1.6b1.7b1.8b

Gross profit

327.2m339.3m335.1m326.0m

Gross profit Margin, %

19%18%17%16%

General and administrative expense

220.6m

Operating expense total

220.6m

EBIT

55.8m30.4m53.8m38.4m

EBIT margin, %

3%2%3%2%

Interest expense

10.6m9.9m6.6m9.5m

Interest income

10.6m9.9m6.6m9.5m

Pre tax profit

45.2m16.2m47.2m28.9m

Income tax expense

26.3m9.4m12.1m7.3m

Net Income

18.9m6.8m35.1m21.6m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q2, 2016Q2, 2017

Revenue

592.0m

Depreciation and amortization

7.0m

Net Income

4.8m(9.7m)8.5m9.6m3.0m2.5m

Pharmerica Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

24.2m33.3m5.4m

Accounts Receivable

199.8m195.7m235.4m

Inventories

110.3m135.7m214.7m

Current Assets

411.7m497.3m552.4m

Goodwill

282.6m317.7m371.0m392.3m

Total Assets

901.4m1.1b1.3b

Accounts Payable

83.8m95.5m107.1m

Short-term debt

12.5m6.4m15.6m

Current Liabilities

151.5m175.8m182.3m

Long-term debt

218.8m344.9m457.8m

Total Debt

231.3m351.3m427.3m473.4m

Additional Paid-in Capital

380.2m394.1m411.1m

Retained Earnings

110.2m117.0m173.7m

Total Equity

462.5m478.1m544.2m

Debt to Equity Ratio

0.5 x0.7 x0.9 x

Debt to Assets Ratio

0.3 x0.3 x0.4 x

Financial Leverage

1.9 x2.2 x2.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

52.4m11.1m7.1m25.2m21.3m40.0m27.4m13.5m7.8m

Accounts Receivable

190.5m188.1m213.7m199.5m199.1m208.1m246.6m249.2m

Inventories

70.3m141.4m133.4m122.6m135.2m160.9m139.6m139.2m

Current Assets

390.5m435.9m466.1m449.7m450.2m494.2m430.0m457.4m455.3m

Goodwill

271.4m286.9m321.5m336.3m336.8m372.2m422.9m449.3m

Total Assets

845.1m923.4m1.0b1.0b1.1b1.1b1.2b1.2b1.3b

Accounts Payable

53.1m59.1m75.5m81.6m80.1m97.4m73.0m104.5m97.1m

Short-term debt

12.5m12.5m2.8m8.9m11.6m11.6m15.5m15.4m

Current Liabilities

108.5m113.0m125.6m132.4m154.8m155.2m168.4m177.8m176.3m

Long-term debt

221.9m256.4m358.1m317.1m338.2m326.0m366.0m400.2m451.0m417.4m444.8m

Total Debt

234.4m230.9m268.9m360.9m326.0m349.8m337.4m377.6m411.8m390.5m466.5m432.9m460.2m

Additional Paid-in Capital

368.9m389.7m391.9m397.9m400.1m408.5m416.0m417.7m419.3m

Retained Earnings

105.8m115.0m105.3m113.8m126.6m128.9m158.7m166.0m181.9m185.1m

Total Equity

456.7m470.0m462.2m472.7m487.1m492.1m526.9m556.8m561.6m

Debt to Equity Ratio

0.5 x

Debt to Assets Ratio

0.3 x

Financial Leverage

1.9 x2 x2.2 x2.1 x2.1 x2.3 x2.2 x2.3 x

Pharmerica Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016

Net Income

6.8m21.6m

Depreciation and Amortization

20.3m33.7m

Accounts Receivable

29.1m(34.3m)

Inventories

(19.0m)(56.7m)

Accounts Payable

(2.9m)(24.0m)36.4m

Cash From Operating Activities

48.4m30.8m

Cash From Investing Activities

(157.0m)(91.7m)

Long-term Borrowings

(231.3m)(11.3m)

Cash From Financing Activities

117.7m43.2m

Interest Paid

7.8m10.6m

Income Taxes Paid

5.3m(4.8m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

Net Income

4.8m8.5m9.6m3.0m7.3m3.5m

Depreciation and Amortization

4.8m4.9m5.8m5.7m11.0m6.2m6.9m

Accounts Receivable

13.1m(1.0m)(1.7m)(2.3m)195.8m1.0m(7.0m)215.4m247.8m

Inventories

2.8m(34.0m)14.9m13.2m117.5m118.8m143.5m81.0m

Accounts Payable

(21.8m)(2.4m)(14.1m)83.3m73.0m86.9m

Cash From Operating Activities

4.4m19.7m44.3m

Cash From Investing Activities

(11.0m)(16.3m)(113.4m)(25.0m)

Long-term Borrowings

(3.1m)(225.0m)

Cash From Financing Activities

(27.0m)400.0k89.7m(27.4m)

Interest Paid

2.0m1.8m1.9m2.1m3.0m

Income Taxes Paid

400.0k1.0m4.7m17.0m
Report incorrect company information

Pharmerica Operating Metrics

FY, 2016

Infusion Centers

19

Pharmacies

103
Report incorrect company information

Pharmerica Employee Rating

2.5291 votes
Culture & Values
2.4
Work/Life Balance
2.8
Senior Management
2.3
Salary & Benefits
2.5
Career Opportunities
2.4
Source